Prognosis of asymptomatic stenosis of the middle cerebral artery
- Correspondence to: Dr Christine Kremer Neurosurgery Department, University Heidelberg, Faculty of Clinical Medicine Mannheim, Theodor-Kutzer-Ufer 1-3, D-68135 Mannheim, Germany; christine.kremernch.ma.uni-heidelberg.de
- Received 2 May 2003
- Accepted 21 December 2003
- Revised 17 November 2003
Abstract
Background: The risk of ischaemic events in asymptomatic intracranial atherosclerosis is unknown.
Objective: To follow up patients with asymptomatic atherosclerotic middle cerebral artery stenosis (MCAS) to evaluate the long term stroke risk in its territory.
Methods: Consecutive white patients with asymptomatic atherosclerotic MCAS were enrolled. Patients with MCAS of possible or proven non-atherosclerotic origin were excluded. MCAS was assessed by transcranial colour duplex sonography according to published angiography validated criteria. Medical treatment was given at the discretion of the treating physician.
Results: 50 patients were included and followed for (mean (SD)) 815 (351) days; three were lost to follow up. MCAS was <50% in 38 and ≥50% in 12. No patient suffered an ischaemic event in the MCAS territory; one had a transient ischaemic attack in the contralateral hemisphere. Three patients died, one from a subdural haematoma in the contralateral hemisphere, and two from non-stroke-related causes. Medical treatment at baseline included antithrombotic drugs in 42 cases (antiplatelet agent, n = 39; warfarin, n = 3), and statins in 22; at the end of follow up 45 of the 47 survivors were on antithrombotic drugs (antiplatelet agent, n = 37; warfarin, n = 8), and 30 were on statins.
Conclusions: Asymptomatic MCAS of atherosclerotic origin appears to have a benign long term prognosis with a low risk of ipsilateral stroke in medically treated white patients.
Footnotes
-
Competing interests : none declared
